Kaplan Meier survival curve for NSCLC patients stratified by PLR systemic inflammation, PLR < 185 and PLR ≥ 185 (n = 184), showing worse survival probability (p = 0.005) for patients having greater inflammation (i.e., above PLR cutoff).
ALI
INFLAMMATION
The hazard ratio for ALI is 0.53 (95% CI: 0.34, 0.82; p = 0.005), indicating that those with higher levels of ALI (i.e., indicative of lower inflammation) had better survival. Patients with baseline ALI<24 (62%) were approximately twice as likely to die than those with higher ALI, having an estimated survival probability of 0.50 (95% CI: 0.41, 0.60). Patients with baseline ALI≥24 (38%) had a one year estimated survival probability of 0.77 (95% CI: 0.77, 0.87). The log-rank test indicated a significant difference in survival (p < 0.005) between groups (